RxDoctor Payments Data

David Carlson, MD

Family Medicine · West Burlington, IANPI 1033285945

Payments from drug & device makers

$572in general payments, 2019–2025

Across 43 payments — averaging $13.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$119
  • Novo Nordisk$110
  • Amgen$68
  • Novartis$53
  • Sunovion Pharmaceuticals Inc.$49
  • Teva Pharmaceuticals USA, Inc.$36
  • plus $138 from 9 others

What the payments were for

  • Food & beverage$56499%
  • Education$81%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$572 in reported general payments places this provider in the 75th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$128,211
Medicare patients
519
Services billed
1,474

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban186$165,410
JardianceEmpagliflozin44$48,808
XareltoRivaroxaban46$36,825
OzempicSemaglutide30$28,634
TrulicityDulaglutide21$19,902
Lantus SolostarInsulin Glargine,hum.Rec.Anlog92$12,938
Spiriva RespimatTiotropium Bromide16$10,227
DuleraMometasone/Formoterol23$10,201
Humalog Kwikpen U-100Insulin Lispro43$9,550
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr19$9,273
SymbicortBudesonide/Formoterol Fumarate31$9,212
Combivent RespimatIpratropium/Albuterol Sulfate19$9,199
Atorvastatin Calcium913$8,836
Qvar RedihalerBeclomethasone Dipropionate12$6,960
Omeprazole482$5,731

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$26$165,410186 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Combivent Respimat$11$68,23479 claims
Johnson & JohnsonXarelto$11$36,82546 claims
Novo NordiskOzempic, Novolog$110$33,43741 claims
Lilly USA, LLCTrulicity$119$19,90221 claims
AstraZenecaSymbicort$11$9,21231 claims
Teva Pharmaceuticals USA, Inc.Qvar Redihaler$36$6,96012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in West Burlington

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →